| Methylnitrosourea induces neural progenitor cell apoptosis and microcephaly in mouse embryos. | |
| | |
MedLine Citation:
|
PMID: 20549696 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Prenatal exposure to methylnitrosourea (MNU), an alkylating agent, induces microcephaly in mice. However, its pathogenetic mechanism has not been clarified, especially that in the development of the cerebral cortex. METHODS: ICR mice were treated with MNU at 10 mg/kg intraperitoneally on day 13.5 or 15.5 of gestation, and the embryos were observed histologically 24 hr after treatment with MNU or at term. To clarify the pathogenesis of microcephaly and histological changes, especially apoptosis, neurogenesis, and neural migration/positioning, we performed histological analysis employing a cell-specific labeling experiment using thymidine-like substances (BrdU, CldU, and IdU) and markers of neurons/neural stem cells. RESULTS: Histological abnormalities of the dorsal telencephalon, and the excessive cell death of proliferative neural progenitor/stem cells were noted in the MNU-treated embryos. The highest frequencies of cell death occurred at 36 hr after MNU treatment, and little or no neurogenesis was observed in the ventricular zone of the dorsal telencephalon. Abnormality of the radial migration was caused by the reduction of radial fibers in the radial glias. Birth-date analysis revealed the abnormal positioning of neurons and aberrant lamination of the cerebral cortex. CONCLUSIONS: Our data suggest that prenatal exposure to MNU induces the excessive cell death of neural precursor/stem cells, and the defective development of the cerebral cortex, resulting in microcephalic abnormalities. |
| | |
Authors:
|
Munekazu Komada; Fusako Fujiyama; Shigehito Yamada; Kohei Shiota; Tetsuji Nagao |
Related Documents
:
|
1638976 - A pdgf receptor mutation in the mouse (patch) perturbs the development of a non-neurona... 8631626 - Increased cell genesis in retinal pigment epithelium of perinatal vitiligo mutant mice. 10741426 - Specific expression of the lim/homeodomain protein lim-1 in horizontal cells during ret... 6648346 - The chick epiblast: a model for examining epithelial morphogenesis. 9299426 - Radiation-induced micronuclei formation in human breast cancer cells: dependence on ser... 1553436 - Estimation of s phase duration in goat epidermis by an in vivo intradermal double label... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Birth defects research. Part B, Developmental and reproductive toxicology Volume: 89 ISSN: 1542-9741 ISO Abbreviation: Birth Defects Res. B Dev. Reprod. Toxicol. Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-06-21 Completed Date: 2010-09-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101155115 Medline TA: Birth Defects Res B Dev Reprod Toxicol Country: United States |
Other Details:
|
Languages: eng Pagination: 213-22 Citation Subset: IM |
Affiliation:
|
Congenital Anomaly Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan. komada@cac.med.kyoto-u.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Apoptosis / drug effects* Body Weight / drug effects Brain / abnormalities, drug effects, embryology Cell Count Cell Differentiation / drug effects Cell Movement / drug effects Embryo, Mammalian / abnormalities*, drug effects, pathology Female Male Methylnitrosourea / toxicity* Mice Mice, Inbred ICR Microcephaly / chemically induced*, embryology* Neurons / drug effects, pathology* Organ Size / drug effects Pregnancy Stem Cells / drug effects, pathology* Telencephalon / drug effects, embryology, pathology |
| Chemical | |
Reg. No./Substance:
|
684-93-5/Methylnitrosourea |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis.
Next Document: Nitrofen induces apoptosis independently of retinaldehyde dehydrogenase (RALDH) inhibition.